Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Myristica fragrans
A prized spice with a dark side — culinary doses are medicinal but larger amounts are dangerously psychoactive.
Nutmeg (Myristica fragrans) is a prized spice with a dual nature: culinary doses (0.5–1 g) provide carminative, mild sedative, and anti-diarrheal benefits, while higher doses (>2 g) risk psychoactive and toxic effects due to compounds like myristicin, elemicin, and safrole. Its traditional uses include digestive aid, insomnia relief, and pain management, and modern research supports hepatoprotective properties, though evidence remains limited (Level C).
Myristicin and elemicin are metabolized to amphetamine-like compounds (e.g., MMDA) via CYP450 enzymes, contributing to mild sedation at low doses and hallucinogenic effects at high doses. Eugenol exhibits anti-inflammatory and analgesic activity through TRPV1 receptor modulation and COX inhibition. The anti-diarrheal effect is attributed to myristicin's anticholinergic properties and eugenol's smooth muscle relaxant action. Hepatoprotection may involve upregulation of antioxidant enzymes (SOD, GPx) and inhibition of lipid peroxidation.
A prized spice with a dark side — culinary doses are medicinal but larger amounts are dangerously psychoactive.
Nutmeg (Myristica fragrans) is a prized spice with a dual nature: culinary doses (0.5–1 g) provide carminative, mild sedative, and anti-diarrheal benefits, while higher doses (>2 g) risk psychoactive and toxic effects due to compounds like myristicin, elemicin, and safrole. Its traditional uses include digestive aid, insomnia relief, and pain management, and modern research supports hepatoprotective properties, though evidence remains limited (Level C).
Myristicin and elemicin are metabolized to amphetamine-like compounds (e.g., MMDA) via CYP450 enzymes, contributing to mild sedation at low doses and hallucinogenic effects at high doses. Eugenol exhibits anti-inflammatory and analgesic activity through TRPV1 receptor modulation and COX inhibition. The anti-diarrheal effect is attributed to myristicin's anticholinergic properties and eugenol's smooth muscle relaxant action. Hepatoprotection may involve upregulation of antioxidant enzymes (SOD, GPx) and inhibition of lipid peroxidation.